Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate

Uribe-San-Martín R.; Ciampi E.; Cruz, J.P.; Vásquez M.; Cárcamo C.

Abstract

We report the case of a 25-year-old woman who developed temporal lobe epilepsy associated with systemic lupus erythematosus (SLE). Serum and cerebrospinal fluid samples showed high titers of anti-ribosomal P (anti-P) antibodies with negative anti-NMDAR antibodies. She was receiving prednisone and azathioprine, with normalization of SLE serum markers, but without changes in titers of anti-P antibodies. No seizure control was achieved using valproic acid, levetiracetam and lamotrigine. However, she had a selective response to topiramate, an AMPAR blocker, maintained during 6 years of follow-up. We discuss the pathophysiology of this autoimmune epilepsy associated with high titer anti-P antibodies.

Más información

Título según WOS: Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate
Título según SCOPUS: Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate
Volumen: 340
Fecha de publicación: 2020
Idioma: English
DOI:

10.1016/j.jneuroim.2020.577144

Notas: ISI, SCOPUS